Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lanni

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Agents and Actions. Supplements|January 1, 1995
New drugs in phase I and beyond workshopR Griffiths, C Lanni
Agents and Actions. Supplements|January 1, 1993
Drugs and lipid mediators workshopC Lanni, D Aharony
Experimental Cell Research|October 15, 1975
Uptake of ionic 55Fe by mouse peritoneal macrophages in vitroM E Fedorko, C Lanni
The American Journal of Pathology|October 1, 1983
Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-PheC Lanni, E L Becker
International Archives of Allergy and Applied Immunology|January 1, 1985
Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide, nordihydroguaiaretic acid, 5,8,11,14-eicosatetraynoic acid and quercetinC Lanni, E L Becker
Biochimica Et Biophysica Acta|March 13, 1981
Localization and partial purification of a neutral-active phospholipase A2 from BCG-induced rabbit alveolar macrophagesC Lanni, R C Franson
Functional Neurology|May 9, 2002
Advances in understanding the pathogenetic mechanisms of Alzheimer's diseaseS Govoni, C Lanni, M Racchi
Current Pharmaceutical Design|April 15, 2010
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disordersC Lanni, S Stanga, M Racchi, et al.
The Biochemical Journal|February 15, 1980
Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents. Modulation by calcium ionsR C Franson, D Eisen, R Jesse, et al.
Anesthesiology|June 1, 1995
Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokineticsE D Kharasch, M D Karol, C Lanni, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Agents and Actions. Supplements|January 1, 1995
New drugs in phase I and beyond workshopR Griffiths, C Lanni
Agents and Actions. Supplements|January 1, 1993
Drugs and lipid mediators workshopC Lanni, D Aharony
Experimental Cell Research|October 15, 1975
Uptake of ionic 55Fe by mouse peritoneal macrophages in vitroM E Fedorko, C Lanni
The American Journal of Pathology|October 1, 1983
Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-PheC Lanni, E L Becker
International Archives of Allergy and Applied Immunology|January 1, 1985
Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide, nordihydroguaiaretic acid, 5,8,11,14-eicosatetraynoic acid and quercetinC Lanni, E L Becker
Biochimica Et Biophysica Acta|March 13, 1981
Localization and partial purification of a neutral-active phospholipase A2 from BCG-induced rabbit alveolar macrophagesC Lanni, R C Franson
Functional Neurology|May 9, 2002
Advances in understanding the pathogenetic mechanisms of Alzheimer's diseaseS Govoni, C Lanni, M Racchi
Current Pharmaceutical Design|April 15, 2010
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disordersC Lanni, S Stanga, M Racchi, et al.
The Biochemical Journal|February 15, 1980
Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents. Modulation by calcium ionsR C Franson, D Eisen, R Jesse, et al.
Anesthesiology|June 1, 1995
Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokineticsE D Kharasch, M D Karol, C Lanni, et al.
Pageof 4